Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin α-4-β-1 (VLA-4) with natalizumab can overcome this resistance-Reference-Cited by-同舟云学术

Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin α-4-β-1 (VLA-4) with natalizumab can overcome this resistance

Published:2011-07-12 Issue:1 Volume:155 Page:53-64
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Mraz Marek,Zent Clive S.,Church Amy K.,Jelinek Diane F.,Wu Xiaosheng,Pospisilova Sarka,Ansell Stephen M.,Novak Anne J.,Kay Neil E.,Witzig Thomas E.,Nowakowski Grzegorz S.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2011.08794.x/fullpdf

Reference63 articles.

1. Differential expression of very late activation antigen-3 (VLA-3)/VLA-4 in B-cell non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia;Baldini;Blood,1992

2. CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin’s lymphoma;Bertolini;Cancer Research,2002

3. Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions;Bonavida;Oncogene,2007

4. Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia;Buchner;Blood,2010a

5. The microenvironment differentially impairs passive and active immunotherapy in chronic lymphocytic leukaemia - CXCR4 antagonists as potential adjuvants for monoclonal antibodies;Buchner;British Journal of Haematology,2010b

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the redox vulnerability of acute myeloid leukaemia cells with a combination of auranofin and vitamin C;British Journal of Haematology;2024-08

2. Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drugs;Leukemia;2024-06-14

3. LncRNA CHROMR/miR-27b-3p/MET axis promotes the proliferation, invasion, and contributes to rituximab resistance in diffuse large B-cell lymphoma;Journal of Biological Chemistry;2024-03

4. Imaging Very Late Antigen-4 on MOLT4 Leukemia Tumors with Cysteine Site-Specific ⁸⁹Zr-Labeled Natalizumab Immuno-Positron Emission Tomography;Molecular Pharmaceutics;2024-01-29

5. Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignancies;Frontiers in Cell and Developmental Biology;2023-10-31